A pharmacovigilance study to determine risk of mortality in male and female patients with Alzheimer's disease using Rivastigmine
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2023.
第一著者: | Shehab, Habibul Mohsin |
---|---|
その他の著者: | Yasmin, Hasina |
フォーマット: | 学位論文 |
言語: | English |
出版事項: |
Brac University
2024
|
主題: | |
オンライン・アクセス: | http://hdl.handle.net/10361/22683 |
類似資料
-
Gender-specific Rhabdomyolysis risk in Alzheimer’s disease patients receiving memantine: a pharmacovigilance study
著者:: Tabassum, Nadira
出版事項: (2024) -
Signal detection of rhabdomyolysis and death for rivastigmine: a pharmacovigilance study
著者:: Mahee, Sadique Abdal
出版事項: (2024) -
Efficacy of Rivastigmine in Alzheimer’s disease- A structured seview
著者:: Alim, Abdul
出版事項: (2023) -
Signal detection of Rhabdomyolysis and death for galantamine: a pharmacovigilance study
著者:: Karmaker, Swastika
出版事項: (2024) -
A pharmacovigilance study on Donepezil: signal detection of rhabdomyolysis and death
著者:: Jahan, Nusrat
出版事項: (2023)